• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

验证用于识别非黑素瘤皮肤癌的理赔数据算法。

Validation of claims data algorithms to identify nonmelanoma skin cancer.

机构信息

Department of Dermatology, Henry Ford Hospital, Detroit, Michigan 48202, USA.

出版信息

J Invest Dermatol. 2012 Aug;132(8):2005-9. doi: 10.1038/jid.2012.98. Epub 2012 Apr 5.

DOI:10.1038/jid.2012.98
PMID:22475754
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3393824/
Abstract

Health maintenance organization (HMO) administrative databases have been used as sampling frames for ascertaining nonmelanoma skin cancer (NMSC). However, because of the lack of tumor registry information on these cancers, these ascertainment methods have not been previously validated. NMSC cases arising from patients served by a staff model medical group and diagnosed between 1 January 2007 and 31 December 2008 were identified from claims data using three ascertainment strategies. These claims data cases were then compared with NMSC identified using natural language processing (NLP) of electronic pathology reports (EPRs), and sensitivity, specificity, positive and negative predictive values were calculated. Comparison of claims data-ascertained cases with the NLP demonstrated sensitivities ranging from 48 to 65% and specificities from 85 to 98%, with ICD-9-CM ascertainment demonstrating the highest case sensitivity, although the lowest specificity. HMO health plan claims data had a higher specificity than all-payer claims data. A comparison of EPR and clinic log registry cases showed a sensitivity of 98% and a specificity of 99%. Validation of administrative data to ascertain NMSC demonstrates respectable sensitivity and specificity, although NLP ascertainment was superior. There is a substantial difference in cases identified by NLP compared with claims data, suggesting that formal surveillance efforts should be considered.

摘要

健康维护组织(HMO)管理数据库已被用作确定非黑素瘤皮肤癌(NMSC)的抽样框架。然而,由于这些癌症缺乏肿瘤登记信息,这些确定方法以前没有得到验证。从 2007 年 1 月 1 日至 2008 年 12 月 31 日期间,从索赔数据中确定了由员工模式医疗集团服务的患者中发生的 NMSC 病例,并使用三种确定策略对这些病例进行了识别。然后,将这些索赔数据病例与使用电子病理学报告(EPR)的自然语言处理(NLP)确定的 NMSC 进行比较,并计算了敏感性、特异性、阳性预测值和阴性预测值。与 NLP 的索赔数据确定病例的比较表明,敏感性范围为 48%至 65%,特异性范围为 85%至 98%,ICD-9-CM 确定的敏感性最高,但特异性最低。HMO 健康计划的索赔数据比所有支付者的索赔数据具有更高的特异性。EPR 和诊所日志登记处病例的比较显示,敏感性为 98%,特异性为 99%。对行政数据进行 NMSC 确定的验证表明,尽管 NLP 确定的敏感性和特异性相当高,但具有良好的敏感性和特异性。NLP 确定的病例与索赔数据之间存在很大差异,表明应考虑进行正式监测。

相似文献

1
Validation of claims data algorithms to identify nonmelanoma skin cancer.验证用于识别非黑素瘤皮肤癌的理赔数据算法。
J Invest Dermatol. 2012 Aug;132(8):2005-9. doi: 10.1038/jid.2012.98. Epub 2012 Apr 5.
2
Identification of patients with nonmelanoma skin cancer using health maintenance organization claims data.利用健康维护组织理赔数据识别非黑素瘤皮肤癌患者。
Am J Epidemiol. 2010 Jan 1;171(1):123-8. doi: 10.1093/aje/kwp352. Epub 2009 Dec 6.
3
Application of Recursive Partitioning to Derive and Validate a Claims-Based Algorithm for Identifying Keratinocyte Carcinoma (Nonmelanoma Skin Cancer).递归分区在确定基于索赔的角化细胞癌(非黑色素瘤皮肤癌)识别算法中的应用。
JAMA Dermatol. 2016 Oct 1;152(10):1122-1127. doi: 10.1001/jamadermatol.2016.2609.
4
Validity of Natural Language Processing for Ascertainment of and Test Results in SEER Cases of Stage IV Non-Small-Cell Lung Cancer.自然语言处理在监测美国国立癌症研究所监测、流行病学和最终结果(SEER)项目中IV期非小细胞肺癌病例的[具体内容缺失]和检测结果方面的有效性。
JCO Clin Cancer Inform. 2019 May;3:1-15. doi: 10.1200/CCI.18.00098.
5
Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.美国 2012 年人群中非黑色素瘤皮肤癌(角质形成细胞癌)的发病率估计。
JAMA Dermatol. 2015 Oct;151(10):1081-6. doi: 10.1001/jamadermatol.2015.1187.
6
No end in sight: the skin cancer epidemic continues.看不到尽头:皮肤癌流行仍在继续。
Semin Cutan Med Surg. 2011 Mar;30(1):3-5. doi: 10.1016/j.sder.2011.01.002.
7
Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992-2003.1992 - 2003年苏格兰东部非黑素瘤皮肤癌发病率的近期趋势
Br J Dermatol. 2007 Jun;156(6):1295-300. doi: 10.1111/j.1365-2133.2007.07892.x.
8
Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: a prospective study in Queensland, Australia.肾移植后非黑色素瘤皮肤癌的发病率及预测:澳大利亚昆士兰州的一项前瞻性研究
Am J Kidney Dis. 2003 Mar;41(3):676-83. doi: 10.1053/ajkd.2003.50130.
9
External validation of a claims-based algorithm for classifying kidney-cancer surgeries.一种基于索赔数据的肾癌手术分类算法的外部验证
BMC Health Serv Res. 2009 Jun 6;9:92. doi: 10.1186/1472-6963-9-92.
10
Upstaging of basal cell and squamous cell carcinomas during definitive surgery: a review of predictive preoperative clinical and histologic features.根治性手术期间基底细胞癌和鳞状细胞癌的升级:预测术前临床和组织学特征的综述。
Arch Dermatol Res. 2021 Jul;313(5):319-325. doi: 10.1007/s00403-020-02151-5. Epub 2020 Oct 27.

引用本文的文献

1
Natural language processing in dermatology: A systematic literature review and state of the art.皮肤科自然语言处理:系统文献回顾与现状
J Eur Acad Dermatol Venereol. 2024 Dec;38(12):2225-2234. doi: 10.1111/jdv.20286. Epub 2024 Aug 16.
2
Development and validation of an automated basal cell carcinoma histopathology information extraction system using natural language processing.使用自然语言处理技术开发并验证一种自动化的基底细胞癌组织病理学信息提取系统。
Front Surg. 2022 Aug 24;9:870494. doi: 10.3389/fsurg.2022.870494. eCollection 2022.
3
Mohs micrographic surgery reduces the need for a repeat surgery for primary Merkel cell carcinoma when compared to wide local excision: A retrospective cohort study of a commercial insurance claims database.与广泛局部切除相比,莫氏显微外科手术减少了原发性默克尔细胞癌重复手术的需求:一项基于商业保险理赔数据库的回顾性队列研究。
JAAD Int. 2022 Aug 27;9:97-99. doi: 10.1016/j.jdin.2022.08.009. eCollection 2022 Dec.
4
Assessment of Electronic Health Record for Cancer Research and Patient Care Through a Scoping Review of Cancer Natural Language Processing.通过癌症自然语言处理的范围综述评估癌症研究和患者护理的电子健康记录。
JCO Clin Cancer Inform. 2022 Jul;6:e2200006. doi: 10.1200/CCI.22.00006.
5
Risk of Nonmelanoma Skin Cancer in Association With Use of Hydrochlorothiazide-Containing Products in the United States.美国使用含氢氯噻嗪产品与非黑色素瘤皮肤癌风险的相关性。
JNCI Cancer Spectr. 2021 Feb 4;5(2). doi: 10.1093/jncics/pkab009. eCollection 2021 Apr.
6
Web Application for the Automated Extraction of Diagnosis and Site From Pathology Reports for Keratinocyte Cancers.用于从角化细胞癌病理报告中自动提取诊断和部位信息的 Web 应用程序。
JCO Clin Cancer Inform. 2020 Aug;4:711-723. doi: 10.1200/CCI.19.00152.
7
Machine Learning in Dermatology: Current Applications, Opportunities, and Limitations.皮肤病学中的机器学习:当前应用、机遇与局限
Dermatol Ther (Heidelb). 2020 Jun;10(3):365-386. doi: 10.1007/s13555-020-00372-0. Epub 2020 Apr 6.
8
Research Techniques Made Simple: An Introduction to Use and Analysis of Big Data in Dermatology.《研究技术简明指南:皮肤病学大数据的使用与分析入门》
J Invest Dermatol. 2017 Aug;137(8):e153-e158. doi: 10.1016/j.jid.2017.04.019.
9
Application of a Natural Language Processing Algorithm to Asthma Ascertainment. An Automated Chart Review.一种自然语言处理算法在哮喘确诊中的应用。自动病历审查。
Am J Respir Crit Care Med. 2017 Aug 15;196(4):430-437. doi: 10.1164/rccm.201610-2006OC.
10
Face Basosquamous Carcinoma, a Case Report.面部基底鳞状细胞癌,病例报告。
Curr Health Sci J. 2014 Oct-Dec;40(4):277-80. doi: 10.12865/CHSJ.40.04.09. Epub 2014 Dec 14.

本文引用的文献

1
Registration in the Danish Regional Nonmelanoma Skin Cancer Dermatology Database: completeness of registration and accuracy of key variables.丹麦区域性非黑色素瘤皮肤癌皮肤病学数据库注册:注册的完整性和关键变量的准确性。
Clin Epidemiol. 2010 Aug 9;2:123-36. doi: 10.2147/clep.s9959.
2
Cancer statistics, 2010.癌症统计数据,2010 年。
CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300. doi: 10.3322/caac.20073. Epub 2010 Jul 7.
3
Incidence estimate of nonmelanoma skin cancer in the United States, 2006.2006年美国非黑色素瘤皮肤癌的发病率估计
Arch Dermatol. 2010 Mar;146(3):283-7. doi: 10.1001/archdermatol.2010.19.
4
Identification of patients with nonmelanoma skin cancer using health maintenance organization claims data.利用健康维护组织理赔数据识别非黑素瘤皮肤癌患者。
Am J Epidemiol. 2010 Jan 1;171(1):123-8. doi: 10.1093/aje/kwp352. Epub 2009 Dec 6.
5
Cancer incidence in five continents. Volume IX.《五大洲癌症发病率》第九卷
IARC Sci Publ. 2008(160):1-837.
6
Changes in nonmelanoma skin cancer incidence between 1977-1978 and 1998-1999 in Northcentral New Mexico.1977 - 1978年至1998 - 1999年新墨西哥州中北部非黑色素瘤皮肤癌发病率的变化。
Cancer Epidemiol Biomarkers Prev. 2003 Oct;12(10):1105-8.
7
Skin cancer is among the most costly of all cancers to treat for the Medicare population.对于医疗保险人群来说,皮肤癌是所有癌症中治疗成本最高的癌症之一。
J Am Acad Dermatol. 2003 Mar;48(3):425-9. doi: 10.1067/mjd.2003.186.